InvestorsHub Logo
icon url

sharpei

01/16/15 2:48 PM

#141309 RE: BuddyGuise #141306

Thank you,
Dr BMT: 'http://www.reuters.com/article/2015/01/15/depomed-jj-pain-idUSL1N0UU2Q320150115'

'pay $1.05 billion to acquire the U.S. rights to Johnson & Johnson's Nucynta opioid pain drug franchise';

'The deal, expected to close in the second quarter,'
icon url

dbg1969

01/16/15 6:45 PM

#141329 RE: BuddyGuise #141306

Do you mean something like a "NEW" 2 bead abuse resistant technology that can be applied to all opioid pain medications? If that was the case it would be prudent for J&J to divest themselves of a soon to be obsolete franchise imo. Probably would not be so advantageous of a move for Depomed Inc. long term however if this proves to be the case imo.
icon url

NASDAQ2020

01/16/15 7:23 PM

#141333 RE: BuddyGuise #141306

Which opiod does Nucynta contain? Or is it different ones?